Review: taking Diovan and Metoprolol tartrate together


Summary

Drug interactions are reported among people who take Diovan and Metoprolol tartrate together. This review analyzes the effectiveness and drug interactions between Diovan and Metoprolol tartrate. It is created by eHealthMe based on reports of 2,814 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Diovan and Metoprolol tartrate >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Diovan

Diovan has active ingredients of valsartan. It is often used in high blood pressure. (latest outcomes from Diovan 53,329 users)

Metoprolol Tartrate

Metoprolol tartrate has active ingredients of metoprolol tartrate. It is often used in high blood pressure. (latest outcomes from Metoprolol tartrate 40,569 users)

On Aug, 23, 2016

2,814 people who take Diovan, Metoprolol Tartrate are studied.


Number of reports submitted per year:

Diovan and Metoprolol tartrate drug interactions.

Drug effectiveness over time:

Diovan:
  • < 1 month: 25.0% - (1 of 4 people)
  • 1 - 6 months: 20.0% - (1 of 5 people)
  • 6 - 12 months: 33.0% - (2 of 6 people)
  • 1 - 2 years: 22.0% - (2 of 9 people)
  • 2 - 5 years: 52.0% - (11 of 21 people)
  • 5 - 10 years: 60.0% - (6 of 10 people)
  • 10+ years: 100.0% - (2 of 2 people)
  • not specified: 0.0% - (0 of 0 people)
Metoprolol Tartrate:
  • < 1 month: 33.0% - (1 of 3 people)
  • 1 - 6 months: 60.0% - (3 of 5 people)
  • 6 - 12 months: 10.0% - (1 of 10 people)
  • 1 - 2 years: 0.0% - (0 of 8 people)
  • 2 - 5 years: 42.0% - (6 of 14 people)
  • 5 - 10 years: 30.0% - (3 of 10 people)
  • 10+ years: 75.0% - (3 of 4 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Diovan:
  • female: 36.0% - (9 of 25 people)
  • male: 50.0% - (16 of 32 people)
Metoprolol Tartrate:
  • female: 20.0% - (5 of 24 people)
  • male: 40.0% - (12 of 30 people)

Drug effectiveness by age:

Diovan:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 50.0% - (1 of 2 people)
  • 40-49: 75.0% - (6 of 8 people)
  • 50-59: 30.0% - (3 of 10 people)
  • 60+: 40.0% - (15 of 37 people)
Metoprolol Tartrate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 50.0% - (1 of 2 people)
  • 40-49: 25.0% - (2 of 8 people)
  • 50-59: 40.0% - (4 of 10 people)
  • 60+: 29.0% - (10 of 34 people)

Most common drug interactions over time *:

< 1 month:
  • renal failure
  • anxiety
  • disseminated intravascular coagulation
  • emotional distress
  • fear
  • hepatitis
  • pain
  • renal injury
  • injury
  • multi-organ failure
1 - 6 months:
  • fatigue
  • dyspnoea
  • erythema
  • headache
  • oedema peripheral
  • renal failure
  • abasia
  • burning sensation
  • muscular weakness
  • pain
6 - 12 months:
  • cardiac failure
  • hives
  • acute myocardial infarction
  • blood creatinine increased
  • gout
  • hypertension
  • malaise
  • renal impairment
  • adrenal neoplasm
  • benign prostatic hyperplasia
1 - 2 years:
  • nausea
  • coronary artery disease
  • palpitations
  • angina pectoris
  • anxiety
  • blood cholesterol increased
  • blood creatine phosphokinase increased
  • bronchitis
  • cardiac failure congestive
  • depression
2 - 5 years:
  • chest discomfort
  • angina pectoris
  • dyspnoea
  • anxiety
  • hypoaesthesia
  • insomnia
  • musculoskeletal pain
  • pain
  • emotional distress
  • hypertension
5 - 10 years:
  • anxiety
  • emotional distress
  • injury
  • leukocyte alkaline phosphatase increased
  • pain
  • renal failure
  • blood pressure increased
  • fear
  • renal impairment
  • renal injury
10+ years:
  • acute myocardial infarction
  • anxiety
  • coronary artery occlusion
  • renal impairment
  • anhedonia
  • death
  • emotional distress
  • fatigue
  • fear
  • injury
not specified:
  • dizziness
  • dyspnoea
  • pain
  • asthenia
  • nausea
  • fatigue
  • diarrhoea
  • oedema peripheral
  • anxiety
  • atrial fibrillation

Most common drug interactions by gender *:

female:
  • dizziness
  • nausea
  • dyspnoea
  • pain
  • hypertension
  • asthenia
  • oedema peripheral
  • diarrhoea
  • atrial fibrillation
  • fall
male:
  • dyspnoea
  • pain
  • dizziness
  • fatigue
  • asthenia
  • hypotension
  • anxiety
  • oedema peripheral
  • cardiac failure congestive
  • diarrhoea

Most common drug interactions by age *:

0-1:
  • anaemia neonatal
  • congenital genitourinary abnormality
  • foetal exposure during pregnancy
  • hyperbilirubinaemia
  • hypoglycaemia neonatal
  • inguinal hernia
  • neonatal respiratory distress syndrome
  • patent ductus arteriosus
  • premature baby
  • retinopathy
2-9:
  • urticaria
10-19:
  • deep vein thrombosis
  • injection site erythema
  • injection site pruritus
  • injection site reaction
  • injection site recall reaction
  • skin plaque
20-29:
  • grand mal convulsion
  • nausea
  • peritonitis
  • thrombocytopenia
  • blood pressure increased
  • body temperature increased
  • depressed level of consciousness
  • diabetic complication
  • diabetic ketoacidosis
  • drug maladministration
30-39:
  • fatigue
  • depression
  • dyspnoea
  • hypotension
  • asthenia
  • convulsion
  • diastolic dysfunction
  • dizziness
  • dysarthria
  • headache
40-49:
  • pain
  • anxiety
  • vomiting
  • cardiac failure congestive
  • depression
  • diarrhoea
  • hypertension
  • oedema peripheral
  • nausea
  • renal failure acute
50-59:
  • pain
  • dyspnoea
  • diarrhoea
  • anxiety
  • fatigue
  • oedema peripheral
  • dizziness
  • asthenia
  • cardiac failure congestive
  • pain in extremity
60+:
  • dizziness
  • atrial fibrillation
  • nausea
  • dyspnoea
  • asthenia
  • fall
  • myocardial infarction
  • hypertension
  • pain
  • fatigue

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Diovan and Metoprolol tartrate?

Can you answer these questions?

More questions for: Diovan, Metoprolol tartrate

You may be interested in these reviews

More reviews for: Diovan, Metoprolol tartrate

On eHealthMe, Diovan (valsartan) is often used to treat high blood pressure. Metoprolol tartrate (metoprolol tartrate) is often used to treat high blood pressure. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.